Cero Therapeutics Holdings, INC. (CEROW) SEC Filings — 2024
49 SEC filings for Cero Therapeutics Holdings, INC. (CEROW) in 2024.
Filings
- Cero Therapeutics Files 8-K on Equity Sales — 8-K · Dec 31, 2024
- Cero Therapeutics Holdings Files S-1 Registration — S-1 · Dec 23, 2024
- Cero Therapeutics Holdings, INC. SC 13G Filing — SC 13G · Dec 13, 2024
- Cero Therapeutics Appoints New CMO, CSO, and Directors — 8-K · Dec 6, 2024
- Cero Therapeutics Files for IPO — S-1 · Nov 27, 2024
- Cero Therapeutics Holdings Inc. Files S-1/A Amendment — S-1/A · Nov 25, 2024
- Cero Therapeutics Files 10-Q/A Amendment — 10-Q/A · Nov 20, 2024
- Cero Therapeutics Holdings, INC. SC 13G/A Filing — SC 13G/A · Nov 20, 2024
- Cero Therapeutics Files Q3 2024 Report — 10-Q · Nov 19, 2024
- Cero Therapeutics Holdings, Inc. Files 8-K — 8-K · Nov 18, 2024
- Cero Therapeutics Holdings, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Cero Therapeutics Files 8-K on Agreements and Shareholder Votes — 8-K · Nov 12, 2024
- Cero Therapeutics Faces Delisting Notice — 8-K · Nov 1, 2024
- Atwood Trust Files SC 13D for Cero Therapeutics — SC 13D · Oct 30, 2024
- Cero Therapeutics Faces Nasdaq Delisting Warning — 8-K · Oct 25, 2024
- Cero Therapeutics Holdings Files S-1/A Amendment — S-1/A · Oct 22, 2024
- Cero Therapeutics Files S-1 for Public Offering — S-1 · Oct 21, 2024
- Cero Therapeutics Holdings Files Definitive Proxy Statement — DEF 14A · Oct 15, 2024
- Cero Therapeutics Announces CMO Departure, Interim Appointment — 8-K · Oct 11, 2024
- Cero Therapeutics Files 8-K with Corporate Updates — 8-K · Oct 2, 2024
- Cero Therapeutics to be Acquired by 03 Life Sciences — 8-K · Sep 26, 2024
- Cero Therapeutics Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Sep 25, 2024
- Cero Therapeutics Appoints New CMO, Director — 8-K · Sep 23, 2024
- Cero Therapeutics Holdings, Inc. Files 8-K — 8-K · Sep 18, 2024
- Cero Therapeutics Holdings Files 8-K — 8-K · Sep 10, 2024
- Cero Therapeutics Holdings DEF 14A Filing — DEF 14A · Aug 26, 2024
- Cero Therapeutics Holdings Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Cero Therapeutics Files 8-K, Updates Business Address — 8-K · Jul 26, 2024
- Cero Therapeutics Faces Delisting Notice — 8-K · Jul 25, 2024
- Cero Therapeutics Files S-1/A Amendment for IPO — S-1/A · Jun 27, 2024
- Cero Therapeutics Files IPO Amendment — S-1/A · Jun 5, 2024
- Cero Therapeutics Holdings Files Q1 2024 10-Q — 10-Q · May 17, 2024
- Cero Therapeutics Holdings, Inc. Files S-1 Registration Statement — S-1 · May 6, 2024
- Cero Therapeutics Faces Delisting Notice — 8-K · May 3, 2024
- Cero Therapeutics Holdings Files 8-K on Security Holder Vote — 8-K · May 1, 2024
- Cero Therapeutics Holdings, Inc. Files Amendment to S-1 Registration Statement — S-1/A · Apr 26, 2024
- Cero Therapeutics Holdings, Inc. Announces 2024 Special Meeting of Stockholders — DEF 14A · Apr 15, 2024
- Cero Therapeutics Holdings, Inc. Files S-1 Registration Statement — S-1 · Apr 10, 2024
- Cero Therapeutics Holdings, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 2, 2024
- CERO Therapeutics Enters Material Agreement, Sells Equity — 8-K · Feb 28, 2024
- CERO THERAPEUTICS Amends 8-K for Acquisition & Control Changes — 8-K/A · Feb 27, 2024
- Cero Therapeutics Holdings, INC. SC 13G/A Filing — SC 13G/A · Feb 22, 2024
- Phoenix Biotech Sponsor Amends CERO Therapeutics Holdings Stake — SC 13D/A · Feb 20, 2024
- CERO THERAPEUTICS Undergoes Major Corporate Restructuring — 8-K · Feb 15, 2024
- PBAX Enters Material Definitive Agreement — 8-K · Feb 14, 2024
- PBAX Files 8-K on Shareholder Vote Submission, Other Events — 8-K · Feb 12, 2024
- Saba Capital Amends Phoenix Biotech SPAC Stake — SC 13G/A · Feb 8, 2024
- PBAX Files 8-K: Material Agreement & Unregistered Equity Sales — 8-K · Feb 6, 2024
- PBAX Files 8-K on Rule 425 Communications, Signaling Deal Progress — 8-K · Jan 5, 2024